Investors

Event Details

Allakos Lirentelimab(AK002) Subcutaneous and Prevalence study results

Oct 26, 2020 at 8:00 AM EDT

877-407-9039  Investors Dial
201-689-8470 Int’l Investors Dial
13712474 Conference ID
 

Data Provided by Refinitiv. Minimum 15 minutes delayed.